Article Versions Notes

Kosaka Y, Yamamoto Y, Tanino H, Nishimiya H, Yamamoto-Ibusuki M, Hirota Y, Iwase H, Nakamura S, Akashi-Tanaka S. BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study. Diagnostics. 2020; 10(2):119. https://doi.org/10.3390/diagnostics10020119

Kosaka, Yoshimasa, Yutaka Yamamoto, Hirokazu Tanino, Hiroshi Nishimiya, Mutsuko Yamamoto-Ibusuki, Yuko Hirota, Hirotaka Iwase, Seigo Nakamura, and Sadako Akashi-Tanaka. 2020. "BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study" Diagnostics 10, no. 2: 119. https://doi.org/10.3390/diagnostics10020119

Kosaka, Y., Yamamoto, Y., Tanino, H., Nishimiya, H., Yamamoto-Ibusuki, M., Hirota, Y., Iwase, H., Nakamura, S., & Akashi-Tanaka, S. (2020). BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study. Diagnostics, 10(2), 119. https://doi.org/10.3390/diagnostics10020119